Cannabinoid signaling in cancer
The family of chemical structures that interact with a cannabinoid receptor are broadly
termed cannabinoids. Traditionally known for their psychotropic effects and their use as …
termed cannabinoids. Traditionally known for their psychotropic effects and their use as …
Cannabinoids and cancer: pros and cons of an antitumour strategy
In the last two decades, research has dramatically increased the knowledge of cannabinoids
biology and pharmacology. In mammals, compounds with properties similar to active …
biology and pharmacology. In mammals, compounds with properties similar to active …
Cannabinoid receptor systems: therapeutic targets for tumour intervention
S Jones, J Howl - Expert Opinion on Therapeutic Targets, 2003 - Taylor & Francis
The past decade has witnessed a rapid expansion of our understanding of the biological
roles of cannabinoids and their cognate receptors. It is now certain that Δ9 …
roles of cannabinoids and their cognate receptors. It is now certain that Δ9 …
The current state and future perspectives of cannabinoids in cancer biology
P Śledziński, J Zeyland, R Słomski… - Cancer medicine, 2018 - Wiley Online Library
To date, cannabinoids have been allowed in the palliative medicine due to their analgesic
and antiemetic effects, but increasing number of preclinical studies indicates their anticancer …
and antiemetic effects, but increasing number of preclinical studies indicates their anticancer …
Receptor-dependent and receptor-independent endocannabinoid signaling: a therapeutic target for regulation of cancer growth
The endocannabinoid system comprises the G-protein coupled CB1 cannabinoid receptor
(CB1R) and CB2 cannabinoid receptor (CB2R), their endogenous ligands …
(CB1R) and CB2 cannabinoid receptor (CB2R), their endogenous ligands …
Cannabinoids as anticancer drugs: current status of preclinical research
B Hinz, R Ramer - British journal of cancer, 2022 - nature.com
Drugs that target the endocannabinoid system are of interest as pharmacological options to
combat cancer and to improve the life quality of cancer patients. From this perspective …
combat cancer and to improve the life quality of cancer patients. From this perspective …
Cannabinoids for cancer treatment: progress and promise
Cannabinoids are a class of pharmacologic compounds that offer potential applications as
antitumor drugs, based on the ability of some members of this class to limit inflammation, cell …
antitumor drugs, based on the ability of some members of this class to limit inflammation, cell …
Endocannabinoid system as a regulator of tumor cell malignancy–biological pathways and clinical significance
M Pyszniak, J Tabarkiewicz… - OncoTargets and therapy, 2016 - Taylor & Francis
The endocannabinoid system (ECS) comprises cannabinoid receptors (CBs), endogenous
cannabinoids, and enzymes responsible for their synthesis, transport, and degradation of …
cannabinoids, and enzymes responsible for their synthesis, transport, and degradation of …
Cannabinoids as prospective anti-cancer drugs: mechanism of action in healthy and cancer cells
Ö Boyacıoğlu, P Korkusuz - … Medicine, Volume 19: Perspectives in Diverse …, 2022 - Springer
Endogenous and exogenous cannabinoids modulate many physiological and pathological
processes by binding classical cannabinoid receptors 1 (CB1) or 2 (CB2) or non …
processes by binding classical cannabinoid receptors 1 (CB1) or 2 (CB2) or non …